🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ATRN-119

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors.

Tags: DNA damage response, biopharmaceutical, cancer therapeutics, clinical trial

Symbol: APRE

Recent Price: $3.48

Industry: Biotechnology

CEO: Dr. Oren Gilad Ph.D.

Sector: Healthcare

Employees: 7

Address: 535 Boylston St., Boston, MA 02116

Phone: 617-463-9385

Last updated: 2024-12-31